Loading: 100%
INC Research Holdings, Inc. logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 6,800 (as per Q2 2016)no data available
Sector Medical Diagnostics & Research, HealthcareMedical Diagnostics & Research, Healthcareno data available
Ticker INCRno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common Shares, Class ANov. 16Jan. 17März 17Mai 17Juli 17Sep. 174045505560
datesClosing price (adj.)
13.10.201754.75
11.10.201754.75
04.10.201753.80
27.09.201751.65
20.09.201753.80
13.09.201755.00
06.09.201758.40
30.08.201758.35
23.08.201756.50
16.08.201755.50
09.08.201755.95
02.08.201756.45
26.07.201756.40
19.07.201756.95
12.07.201757.50
05.07.201757.53
27.06.201758.80
20.06.201759.05
13.06.201759.25
06.06.201758.05
30.05.201756.30
23.05.201755.70
16.05.201757.10
09.05.201743.65
02.05.201743.40
25.04.201744.30
18.04.201742.95
11.04.201743.20
04.04.201744.65
28.03.201743.50
21.03.201743.90
14.03.201744.60
07.03.201745.85
28.02.201743.65
21.02.201754.05
14.02.201754.15
07.02.201752.70
31.01.201753.00
24.01.201750.85
17.01.201751.25
10.01.201753.20
03.01.201751.85
27.12.201651.60
19.12.201650.45
12.12.201650.60
05.12.201649.55
28.11.201650.00
21.11.201650.70
14.11.201650.75
07.11.201646.70
31.10.201645.70
24.10.201646.80
17.10.201644.50
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
54.75n/a
Market Capitalisation
in million USD
2,995n/a
Enterprise Value
in million USD
3,376n/a
Common Shares Outstanding
as per Jul 21, 2016
54,705,984n/a
Preferred Shares Outstanding
as per Jul 21, 2016
n/a
Average Basic Shares Outstanding
TTM
55,082,750n/a
Average Diluted Shares Outstanding
TTM
57,239,250n/a
Index Membership
n/a
Business Summary
INC Research Holdings Inc is a Contract Research Organization providing clinical development services for biopharmaceutical & medical device industries. It operates in North America, Europe, Middle East and Africa, Asia-Pacific and Latin America.
no data available
Key Financials & Ratios (all figures TTM as per , million USD, full statements further below)
Profit & Loss
Revenues 0n/a
Gross Profit 0n/a
Operating Income 0n/a
EBITDA 0n/a
Net Profit 0n/a
Balance Sheet
Cash and Cash Equivalents 92n/a
Receivables 0n/a
Total Current Assets 484n/a
PP&E 46n/a
Total Assets 1,252n/a
Accounts Payable 27n/a
Current Debt 16n/a
Total Current Liabilities 474n/a
Long-Term Debt 457n/a
Total Liabilities 963n/a
Total Equity 289n/a
Cash Flow
Depreciation & Amortisation 57n/a
Change in Working Capital -47n/a
Operating Cash Flow 154n/a
Net Change in PP&E and Intangibles -25n/a
Investing Cash Flow -25n/a
Dividends Paid 0n/a
Financing Cash Flow -125n/a
Total Change in Cash -7n/a
Free Cash Flow 0n/a
Profitability Ratios
Gross Margin 0.0%n/a
Operating Margin 0.0%n/a
Net Profit Margin 0.0%n/a
Return on Equity 0.0%n/a
Return on Assets 0.0%n/a
Per Share Figures
Basic EPS n/a
Diluted EPS n/a
Sales per Share n/a
Book Value per Share 5.24n/a
FCF per Share n/a
Dividends per Share 0.00n/a
Price Multiples
Price to Earnings Ratio n/a
Price to Sales Ratio n/a
Price to Book Value 10.45n/a
Price to Free Cash Flow n/a
Valuation Metrics
EV/EBITDA n/a
EV/Sales n/a
Book to Market Value 0.10n/a
Other Ratios
Current Ratio 102.1%n/a
Liabilities to Equity Ratio 333.8%n/a
Debt to Assets Ratio 37.7%n/a
Profit & Loss StatementP&L data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '12FY '13FY '14FY '15
Revenue
869
995
1,179
1,399
Sales & Services Revenue
0
0
0
0
Financing Revenue
0
0
0
0
Other Revenue
0
0
0
0
Cost of revenue
-679
-775
-884
-1,027
Cost of Goods & Services
0
0
0
0
Cost of Financing Revenue
0
0
0
0
Cost of Other Revenue
0
0
0
0
Gross Profit
190
220
295
372
Other Operating Income
0
0
0
0
Operating Expenses
-148
-138
-156
-176
Selling, General & Administrative
-109
-118
-145
-157
Selling & Marketing
0
0
0
0
General & Administrative
0
0
0
0
Research & Development
0
0
0
0
Depreciation & Amortization
-39
-20
-11
-20
Provision For Doubtful Accounts
0
0
0
0
Other Operating Expense
0
0
0
0
Operating Income (Loss)
42
82
138
196
Non-Operating Income (Loss)
-67
-59
-61
-20
Interest Expense, net
-62
-61
-53
-16
Interest Expense
0
0
0
0
Interest Income
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
Other Non-Operating Income (Loss)
-5
2
-8
-4
Pretax Income (Loss), Adjusted
-25
23
77
176
Abnormal Gains (Losses)
31
12
44
9
Acquired In-Process R&D
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
Abnormal Derivatives
0
0
0
0
Disposal of Assets
0
0
0
0
Early extinguishment of Debt
0
0
0
0
Asset Write-Down
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
Sale of Business
0
0
0
0
Legal Settlement
0
0
0
0
Restructuring Charges
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
Insurance Settlement
0
0
0
0
Other Abnormal Items
0
0
0
0
Pretax Income (Loss)
6
35
121
186
Income Tax (Expense) Benefit, net
36
-11
5
-14
Current Income Tax
0
0
0
0
Deferred Income Tax
0
0
0
0
Tax Allowance/Credit
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
Income (Loss) from Continuing Operations
42
24
126
172
Net Extraordinary Gains (Losses)
0
0
0
0
Discontinued Operations
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
Income (Loss) Including Minority Interest
42
24
126
172
Minority Interest
0
0
0
0
Net Income
42
24
126
172
Preferred Dividends
-1
-1
0
0
Other Adjustments
0
0
0
0
Net Income Available to Common Shareholders
41
24
125
172
Remarks
restated on Feb 24, 2015 n/a
calculated values,
restated on Feb 25, 2016 n/a
calculated values,
restated on Feb 25, 2016 n/a
calculated values,
restated on Feb 25, 2016 n/a
calculated values,
Balance SheetBS data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '12FY '13FY '14FY '15
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
97
126
85
Cash & Cash Equivalents
n/a
97
126
85
Short Term Investments
n/a
0
0
0
Accounts & Notes Receivable
n/a
0
0
0
Accounts Receivable, Net
n/a
0
0
0
Notes Receivable, Net
n/a
0
0
0
Unbilled Revenues
n/a
0
0
0
Inventories
n/a
0
0
0
Raw Materials
n/a
0
0
0
Work In Process
n/a
0
0
0
Finished Goods
n/a
0
0
0
Other Inventory
n/a
0
0
0
Other Short Term Assets
n/a
279
300
337
Prepaid Expenses
n/a
35
35
39
Derivative & Hedging Assets
n/a
0
0
0
Assets Held-for-Sale
n/a
0
0
0
Deferred Tax Assets
n/a
14
16
0
Income Taxes Receivable
n/a
0
0
0
Discontinued Operations
n/a
0
0
0
Miscellaneous Short Term Assets
n/a
229
249
298
Total Current Assets
n/a
376
426
422
Property, Plant & Equipment, Net
n/a
41
44
45
Property, Plant & Equipment
n/a
0
0
0
Accumulated Depreciation
n/a
0
0
0
Long Term Investments & Receivables
n/a
0
0
0
Long Term Investments
n/a
0
0
0
Long Term Marketable Securities
n/a
0
0
0
Long Term Receivables
n/a
0
0
0
Other Long Term Assets
n/a
816
771
744
Intangible Assets
n/a
231
190
152
Goodwill
n/a
563
557
553
Other Intangible Assets
n/a
0
0
0
Prepaid Expense
n/a
0
0
0
Deferred Tax Assets
n/a
4
16
12
Derivative & Hedging Assets
n/a
0
0
0
Prepaid Pension Costs
n/a
0
0
0
Discontinued Operations
n/a
0
0
0
Investments in Affiliates
n/a
0
0
0
Miscellaneous Long Term Assets
n/a
18
8
27
Total Noncurrent Assets
n/a
857
815
789
Total Assets
n/a
1,233
1,241
1,211
Liabilities and owners' equity
Payables & Accruals
n/a
104 103815000
128 128203000
134 133759000
Accounts Payable
n/a
10 9594000
17 16548000
22 22497000
Accrued Taxes
n/a
0 0
0 0
0 0
Interest & Dividends Payable
n/a
0 0
0 0
0 0
Other Payables & Accruals
n/a
94 94221000
112 111655000
111 111262000
Short Term Debt
n/a
7 7005000
4 4067000
30 29804000
Short Term Borrowings
n/a
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
Other Short Term Liabilities
n/a
207 207188000
247 246902000
311 311029000
Deferred Revenue
n/a
207 207188000
247 246902000
311 311029000
Derivatives & Hedging
n/a
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
0 0
0 0
0 0
Total Current Liabilities
n/a
318 318008000
379 379172000
475 474592000
Long Term Debt
n/a
587 587474000
412 412190000
472 472035000
Long Term Borrowings
n/a
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
Other Long Term Liabilities
n/a
51 51422000
58 57794000
47 47158000
Accrued Liabilities
n/a
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
29 29233000
30 30368000
28 28066000
Derivatives & Hedging
n/a
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
22 22189000
27 27426000
19 19092000
Total Noncurrent Liabilities
n/a
639 638896000
470 469984000
519 519193000
Total Liabilities
n/a
957 956904000
849 849156000
994 993785000
Preferred Equity
n/a
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
482 481630000
636 635558000
560 560449000
Common Stock
n/a
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
Treasury Stock
n/a
-7 -6751000
0 0
0 0
Retained Earnings
n/a
-189 -188831000
-217 -217149000
-301 -301472000
Other Equity
n/a
-10 -9841000
-26 -26200000
-42 -41543000
Equity Before Minority Interest
n/a
276 276207000
392 392209000
217 217434000
Minority Interest
n/a
0 0
0 0
0 0
Total Equity
n/a
276 276207000
392 392209000
217 217434000
Total Liabilities & Equity
n/a
1,233 1233111000
1,241 1241365000
1,211 1211219000
Remarks restated on n/a restated on Feb 24, 2015 n/a restated on Feb 25, 2016 n/a restated on Jul 28, 2016 n/a
Cash Flow StatementCF data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '12FY '13FY '14FY '15
Net Income/Starting Line
-59
-42
-23
117
Net Income
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
Other Adjustments
0
0
0
0
Depreciation & Amortization
79
58
55
56
Non-Cash Items
-34
14
55
24
Stock-Based Compensation
0
0
0
0
Deferred Income Taxes
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
Change in Working Capital
58
6
45
8
(Increase) Decrease in Accounts Receivable
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
Cash from Operating Activities
43
37
131
205
Change in Fixed Assets & Intangibles
-10
-18
-26
-21
Disposition of Fixed Assets & Intangibles
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
Net Change in Long Term Investment
0
0
0
0
Decrease in Long Term Investment
0
0
0
0
Increase in Long Term Investment
0
0
0
0
Net Cash From Acquisitions & Divestitures
-3
0
-2
0
Net Cash from Divestitures
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
Cash for Joint Ventures
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
Other Investing Activities
0
0
0
0
Net Cash From Discontinued Operations (investing)
0
0
0
0
Cash from Investing Activities
-13
-18
-28
-21
Dividends Paid
-1
-1
0
0
Cash From (Repayment of) Debt
-13
-4
-215
80
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
Cash From Long Term Debt
0
0
0
0
Cash From (Repurchase of) Equity
-2
-1
156
-281
Increase in Capital Stock
0
0
156
4
Decrease in Capital Stock
-3
-1
0
-285
Other Financing Activities
-3
-1
-9
-10
Net Cash From Discontinued Operations (financing)
0
0
0
0
Cash from Financing Activities
-19
-7
-68
-211
Net Cash Before Disc. Operations and FX
11
13
36
-28
Change in Cash from Disc. Operations and Other
0
0
0
0
Net Cash Before FX
11
13
36
-28
Effect of Foreign Exchange Rates
-1
3
-6
-14
Net Changes in Cash
10
16
29
-41
Remarks
restated on Feb 24, 2015 n/a
calculated values,
restated on Feb 25, 2016 n/a
calculated values,
restated on Feb 25, 2016 n/a
calculated values,
restated on Feb 25, 2016 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo